Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
TFPI / LACI is a protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. The product of this gene inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop. The encoded protein is glycosylated and predominantly found in the vascular endothelium and plasma in both free forms and complexed with plasma lipoproteins. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been confirmed.
Gene Name: | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
Synonyms: | TFPI, Anti-convertin, Extrinsic pathway inhibitor, EPI, LACI, TFI, TFPI1 |
Target Sequences: | NM_006287 NP_006278.1 P10646 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.